August 19, 2013
Piramal Imaging Provides Comments in Response to the Centers for Medicare and Medicaid Services (CMS) Proposed Coverage Decision for Beta-Amyloid Positron Emission Tomography (PET).
July 25, 2013
The Centers for Medicare and Medicaid Services (CMS) Draft Decision Could Limit Patient Access to New Technology That May Help in Diagnosing Dementia.
July 12, 2013
Piramal Imaging Highlights New Data for Florbetaben F18 at AAIC 2013.
June 6, 2013
Piramal Imaging Highlights New Data for Florbetaben and Other Investigational Radiopharmaceuticals at SNMMI 2013.
May 7, 2013
Piramal Imaging Welcomes Ana M. Catafau, MD, PhD, as VP, Clinical Research and Development, Neurosciences.
March 21, 2013
Piramal Imaging announces the acceptance for review of [18F] florbetaben by the FDA and EMA for the visual detection of beta-amyloid in Alzheimer’s disease.
August 30, 2012
Indian Pharma MNC Piramal investing in German molecular imaging technology.
April 15, 2012
Piramal Healthcare Limited acquires molecular imaging development portfolio of Bayer Pharma.